Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Endocrinology

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.1.06109PMID 15930173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.

  2004cited by this paper
• Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats.

  2003cited by this paper
• Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.

  2003cited by this paper
• Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment

  2002cited by this paper
• GH administration and renal IGF-I system in arthritic rats.

  2002cited by this paper
• Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats.

  2002cited by this paper
• Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity.

  2002cited by this paper
• Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA.

  2002cited by this paper
• Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment.

  2002cited by this paper
• Physiological-dose steroid therapy in sepsis

  2002cited by this paper
• Hepatic Insulin‐like Growth Factor‐I Binding Protein 3 Gene Expression in Rats with Endotoxic Shock: The Role of Glucocorticoids

  2002cited by this paper
• Physiological-dose steroid therapy in sepsis [ISRCTN36253388]

  2002cited by this paper
• The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA.

  2001cited by this paper
• A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite.

  2001cited by this paper
• Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone.

  2000cited by this paper
• Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

  1999cited by this paper
• Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants.

  1999cited by this paper
• Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.

  1999cited by this paper
• Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes.

  1999cited by this paper
• [Insulin-like growth factor binding protein-3 (IGFBP-3)].

  1999cited by this paper
• Effects of endotoxin lipopolysaccharide administration on the somatotropic axis.

  1998cited by this paper
• Insulin-like growth factors and osteoporosis.

  1997cited by this paper
• Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1.

  1997cited by this paper
• Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin.

  1997cited by this paper
• Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells.

  1996cited by this paper
• Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat.

  1995cited by this paper
• Glucocorticoid regulation of insulin-like growth factor-binding protein-3.

  1995cited by this paper
• Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate.

  1994cited by this paper
• Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin.

  1994cited by this paper
• The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment.

  1994cited by this paper
• In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.

  1994cited by this paper
• Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.

  1993cited by this paper
• Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes.

  1993cited by this paper
• Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery.

  1992cited by this paper
• A simple assay for proteolysis of IGFBP-3.

  1991cited by this paper
• Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat.

  1990cited by this paper
• Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone.

  1990cited by this paper
• The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor.

  1989cited by this paper
• Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat.

  1989influential reference
• Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts.

  1988cited by this paper
• Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues.

  1987cited by this paper

• Targeting the Gut-Brain Axis Through Insulin-like Growth Factors: Therapeutic Implications and Future Directions

  2025cites this paper
• Lower Initial Insulin-like Growth Factor-Binding Protein-3 Concentrations May Reflect Immune Suppression and Predict Increased Risk of Sepsis-Related Mortality

  2025cites this paper
• IGF-1 and IGFBP-3 in Inflammatory Cachexia

  2021cites this paper
• Low serum levels of insulin-like growth factor-1 are associated with an increased risk of rheumatoid arthritis: a systematic review and meta-analysis.

  2019cites this paper
• Temporal and spatial expression of IGF-I and IGFBP-1 during acute-phase response induced by localized inflammation in rats.

  2009cites this paper
• COX-2 ACTIVATION BY ENDOTOXIN MEDIATES THE DECREASE IN IGF-I, BUT NOT IN IGFBP-3, GENE EXPRESSION IN THE LIVER

  2008cites this paper
• Cyclooxygenase-2 [corrected] activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3, [corrected] gene expression in the liver.

  2008cites this paper